Bringing the fundamentals into focus…
Back to Bio-Rad Laboratories, Inc.
How Bio-Rad Laboratories, Inc. stacks up
BIO · against 151 other Healthcare companies of similar size
Growth
25/ 100
Near the bottom of its peers.
Ranked #142 of 152 · scores higher than 7% of peers
Bars: peers in each 10-point band of the growth score11 peers with a growth score of 20–29, including BIO · Click a bar to see the companies
Why growth scores 25?
Weighted metrics compared with all Healthcare companies.Mainly because of its 3-year revenue growth and revenue growth, which are weaker than most Healthcare peers.
- slower revenue growth over three years: weaker than 78% of peers. 3-year revenue growth: -2.7% vs peer median 5.8%
- slower revenue growth over the last year: weaker than 68% of peers. Revenue growth: 0.7% vs peer median 6.1%
- Earnings per share growth is not reported, so it is left out of the score.
Metric by metric
Position: dot = BIO, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | BIO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 152 reported | 0.7% | 10.2% | 13% | 33% | |
| Earnings per share growthHigher is better · 111 reported | Not reported | 14.9% | — | — | 33% |
| 3-year revenue growthHigher is better · 147 reported | -2.7% | 10.9% | 4% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around BIO| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.8B USD | 99 | 31 | |
| 2 | 9.3B USD | 98 | 64 | |
| 3 | 14.87T KRW (≈$10.7B) | 97 | 76 | |
| 3 | 7.3B USD | 97 | 74 | |
| 5 | 16.5B USD | 96 | 37 | |
| 138 | 8.6B USD | 28 | 30 | |
| 138 | 11.9B USD | 28 | 53 | |
| 140 | 12.7B AUD (≈$8.4B) | 27 | 38 | |
| 141 | 1.85T JPY (≈$12.5B) | 26 | 55 | |
| 142 | 10.0B USD | 25 | 43 | |
| 143 | 7.7B USD | 24 | 37 | |
| 143 | 5.5B USD | 24 | 43 | |
| 143 | 16.7B CHF (≈$19.2B) | 24 | 47 | |
| 146 | 9.3B AUD (≈$6.1B) | 21 | 55 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score